Peak nasal inspiratory flow and effect of dupilumab therapy in patients with severe CRSwNP from the SINUS-24 and SINUS-52 studies

被引：0
|
作者：
Desrosiers, M. [1 ]
Nash, S. [2 ]
Lane, A. [3 ]
Lee, S. [4 ]
De Corso, E. [5 ]
Xia, C. [2 ]
Khan, A. [6 ]
Jacob-Nara, J. [7 ]
Sacks, H. [2 ]
Rowe, P. [7 ]
Deniz, Y. [2 ]
机构：
[1] Univ Montreal, Div Otolaryngol Head & Neck Surg, Montreal, PQ, Canada
[2] Regeneron Pharmaceut Inc, Med Affairs, Tarrytown, NY USA
[3] Johns Hopkins Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD USA
[4] Harvard Med Sch, Brigham & Womens Hosp, Div Otolaryngol Head & Neck Surg, Boston, MA USA
[5] A Gemelli Hosp Fdn IRCCS, Otorhinolaryngol Head & Neck Surg, Rome, Italy
[6] Sanofi, Global Med Affairs, Chilly Mazarin, France
[7] Sanofi, Global Med Affairs, Bridgewater, NJ USA
来源：
ALLERGOLOGIE | 2023年 / 46卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P6.10
引用
收藏
页码：549 / 549
页数：1
相关论文
共 39 条
  • [1] Dupilumab efficacy in patients with severe chronic rhinosinusitis with nasal polyposis: Pooled results from the SINUS-24 and SINUS-52 phase 3 studies
    Bachert, C.
    Fokkens, W. J.
    Jankowski, R.
    Cervin, A. U.
    Laidlaw, T. M.
    Lee, S. E.
    Zhang, M.
    Lu, X.
    Amin, N.
    Patel, N.
    Graham, N. M. H.
    Ruddy, M.
    Staudinger, H.
    Mannent, L. P.
    ALLERGY, 2019, 74 : 55 - 56
  • [2] Dupilumab improved objective and patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and complete bilateral nasal obstruction in the SINUS-24 and SINUS-52 studies
    Wagenmann, M.
    Khan, A.
    Bachert, C.
    Hopkins, C.
    Msihid, J.
    Nash, S.
    Deniz, Y.
    Rowe, P.
    Sacks, H.
    Jacob-Nara, J.
    ALLERGOLOGIE, 2023, 46 (08) : 549 - 550
  • [3] Rapid and Sustained Effects of Dupilumab in Patients with Severe Chronic Rhinosinusitis with Nasal Polyps: Analysis of the SINUS-24 and SINUS-52 Phase 3 Trails
    Hellings, P. W.
    Peters, A.
    Chaker, A. M.
    Heffler, E.
    Zhang, H.
    Daizadeh, N.
    Nash, S.
    Khan, A. H.
    Siddiqui, S.
    Jacob-Nara, J. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [4] Dupilumab rapidly improves sense of smell in patients with severe chronic rhinosinusitis with nasal polyps: Pooled results from the SINUS-24 and SINUS-52 phase 3 studies
    Mullol, J.
    Bachert, C.
    Desrosiers, M.
    Han, J. K.
    Jankowski, R.
    Daizadeh, N.
    Amin, N.
    Mannent, L. P.
    Khan, A. H.
    Kamat, S.
    ALLERGY, 2020, 75 : 226 - 226
  • [5] Dupilumab reduces need for systemic corticosteroid use, sinonasal surgery in patients with severe chronic rhinosinusitis with nasal polyps: Pooled results from the SINUS-24, SINUS-52 phase 3 studies
    Desrosiers, M.
    Bachert, C.
    Hellings, P. W.
    Hopkins, C.
    Olze, H.
    Han, J. K.
    Lee, S. E.
    Zhang, M.
    Lu, X.
    Amin, N.
    Patel, N.
    Graham, N. M. H.
    Ruddy, M.
    Staudinger, H.
    Mannent, L. P.
    ALLERGY, 2019, 74 : 330 - 331
  • [6] SNOT-22 items and association with objective measures in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from SINUS-24 and SINUS-52 trials
    Mullol, Joaquim
    Canonica, Giorgio Walter
    Wagenmann, Martin
    Coste, Andre
    Hellings, Peter
    Nash, Scott
    Kamat, Siddhesh
    Mujumdar, Urvi
    Msihid, Jerome
    Khan, Asif H.
    Siddiqui, Shahid
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Rowe, Paul
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [7] Improvement in patient-reported "taste" and association with smell in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from the SINUS-24 and SINUS-52 trials
    Peters, Anju T.
    Soler, Zachary M.
    Kern, Robert C.
    Heffler, Enrico
    Maspero, Jorge F.
    Crampette, Louis
    Fujieda, Shigeharu
    Lane, Andrew P.
    Zhang, Haixin
    Nash, Scott
    Khan, Asif H.
    Siddiqui, Shahid
    Jacob-Nara, Juby A.
    Rowe, Paul
    Deniz, Yamo
    CLINICAL AND EXPERIMENTAL ALLERGY, 2022, 52 (09): : 1105 - 1109
  • [8] Improvement in patient-reported 'taste' and association with smell in dupilumab-treated severe chronic rhinosinusitis with nasal polyps patients from the SINUS-24 and SINUS-52 trials
    Peters, A. T.
    Soler, Z. M.
    Rc, Kern
    Heffler, E.
    Maspero, J. F.
    Crampette, L.
    Fujieda, S.
    Lane, A. P.
    Zhang, H.
    Nash, S.
    Khan, A. H.
    Siddiqui, S.
    Jacob-Nara, J. A.
    Rowe, P.
    Deniz, Y.
    ALLERGY, 2021, 76 : 301 - 302
  • [9] DUPILUMAB IMPROVES PATIENT-REPORTED OUTCOMES IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS AND COMORBID ASTHMA: SINUS-24/SINUS-52 TRIALS
    Gevaert, P.
    Bachert, C.
    Desrosiers, M.
    Mullol, J.
    Maspero, J.
    Zhang, M.
    Mao, X.
    Kamat, S.
    Khan, A.
    Amin, N.
    Staudinger, H.
    Mannent, L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S58 - S59
  • [10] Baseline Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps and Comorbid Asthma from the Pooled Populations of the SINUS-24 and SINUS-52 Dupilumab Phase 3 Trials
    Desrosiers, M.
    Mullol, J.
    Forwith, K.
    Gevaert, P.
    Maspero, J. F.
    Zhang, M.
    Mao, X.
    Amin, N.
    Mannent, L. P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
1234